Breast Cancer Foundation NZ
Worried?
Recently diagnosed?
-
Recently diagnosed?
- Types of breast cancer
- Tests & diagnosis
- Treatment options
- Advanced breast cancer
- Clinical trials
Need help?
Want to help?
-
Want to help?
- Donate
- Get involved
- Volunteer
- Involve your business
- Buy Pink Ribbon
Checked your breasts lately?
We'll show you how. Checking your breasts is easy as TLC. 'Know your normal', so you can find any changes in your breasts as soon as they appear.
-
Touch
Touch both breasts. You’re feeling for any lumps or thickening of the tissue, even up into the armpits. -
Look
Look in front of a mirror. Can you see any physical changes to the breast shape, skin or nipples? -
Check
Check any breast changes with your doctor. Even if you’ve had a mammogram recently.
Latest updates
Our latest events, press releases and blog posts
News
13 September 2024
Funding announced for new "wonder drug"
New Zealand clinicians have collectively pushed for access to Enhertu; a "game changer drug" for advanced HER2-positive breast cancer.
Today, Pharmac announced plans to fund this drug from 1 January 2025.
Blog
05 September 2024
New study: Double mastectomy doesn't improve breast cancer survival
Many women with invasive breast cancer in one breast may opt for a double mastectomy. However, recent research has found no survival benefit when compared to breast conserving surgery (partial mastectomy).
News
06 August 2024
Exciting progress towards a new breast cancer vaccine
The future of prevention against breast cancer recurrence is coming. Overseas, and right here in Aotearoa. Read an update about our exciting project.
Pink Ribbon Press
Pink Ribbon Press Spring 2024
PDF format - 0.8mb
Press release
05 July 2024
Kiwis with advanced triple negative breast cancer get the news they’ve been waiting for
Pharmac announces funding for Keytruda for metastatic triple negative breast cancer from October 1st.
News
18 June 2024
Pharmac reverses eligibility restrictions for life-extending drugs
Positive outcome for patients with advanced HR+/HER2- breast cancer as new treatment available from July 1.